 |
|
|
|
|
 |
|
Thursday, May 18, 2006
Cervical cancer vaccine
Looking to move past the Vioxx controversy, Merck hopes an advisory panel convening today will recommend that the FDA approve the drug maker's experimental vaccine against cervical cancer. Lisa Napoli reports.
 |
DOW 1.36% |
|
NASDAQ 2.28% |
|
S & P 1.71% |
| Details... | |
Browse
The business world can be a real pressure cooker. Don't take out your frustration on the interns — duck into The Marketplace Confessional and let off that steam anonymously.
